These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 21765248)

  • 1. Botulinum toxin type B in the treatment of residual limb hyperhidrosis for lower limb amputees: a pilot study.
    Kern U; Kohl M; Seifert U; Schlereth T
    Am J Phys Med Rehabil; 2011 Apr; 90(4):321-9. PubMed ID: 21765248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].
    Kern KU; Kohl M; Seifert U; Schlereth T
    Schmerz; 2012 Apr; 26(2):176-84. PubMed ID: 22527647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin and hyperhidrosis of the amputation stump in war amputees.
    Mouhli N; Hfaidh M; Abdennadher A; Ben Amor K; Rahali H; Amri K; Maaoui R
    Tunis Med; 2024 Apr; 102(4):200-204. PubMed ID: 38746958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal botulinum toxin type A injection effectively reduces residual limb hyperhidrosis in amputees: a case series.
    Charrow A; DiFazio M; Foster L; Pasquina PF; Tsao JW
    Arch Phys Med Rehabil; 2008 Jul; 89(7):1407-9. PubMed ID: 18586144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of compensatory hyperhidrosis after sympathectomy with botulinum toxin and anticholinergics.
    Karlsson-Groth A; Rystedt A; Swartling C
    Clin Auton Res; 2015 Jun; 25(3):161-7. PubMed ID: 25773586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual Limb Hyperhidrosis and RimabotulinumtoxinB: A Randomized Placebo-Controlled Study.
    Pasquina PF; Perry BN; Alphonso AL; Finn S; Fitzpatrick KF; Tsao JW
    Arch Phys Med Rehabil; 2016 May; 97(5):659-664.e2. PubMed ID: 26812182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin in the treatment of residual limb hyperhidrosis: A systematic review.
    Rocha Melo J; Rodrigues MA; Caetano M; Cantista P
    Rehabilitacion (Madr); 2023; 57(3):100754. PubMed ID: 36791670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Mallin K; Charles C; Martin LK; Black L; Bryde J
    Dermatol Surg; 2005 Mar; 31(3):263-70. PubMed ID: 15841624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin B in the treatment of craniofacial hyperhidrosis.
    Karlqvist M; Rosell K; Rystedt A; Hymnelius K; Swartling C
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1313-7. PubMed ID: 24118460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study.
    Hamdy RC; Montpetit K; Raney EM; Aiona MD; Fillman RR; MacKenzie W; McCarthy J; Chafetz RS; Thomas SS; Tamayo CM; Littleton AG; Ruck-Gibis J; Takahashi SN; Rinaldi M; Finley GA; Platt RW; Dahan-Oliel N
    J Pediatr Orthop; 2009; 29(5):427-34. PubMed ID: 19568011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing residual limb hyperhidrosis in wounded warriors.
    Pace S; Kentosh J
    Cutis; 2016 Jun; 97(6):401-3. PubMed ID: 27416083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical botulinum toxin to treat hyperhidrosis? No sweat!
    Lim EC; Seet RC; Chow A; Oh VM; Ong BK; Wilder-Smith EP
    Med Hypotheses; 2006; 67(1):27-32. PubMed ID: 16524669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B.
    Cabreus P; Swartling C; Rystedt A
    J Dermatol; 2019 Oct; 46(10):874-878. PubMed ID: 31373068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does botulinum toxin A make prosthesis use easier for amputees?
    Kern U; Martin C; Scheicher S; Müller H
    J Rehabil Med; 2004 Sep; 36(5):238-9. PubMed ID: 15626165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.